Antidepressant-Like Effects of Acupuncture: Insights From DNA Methylation and Histone Modifications of Brain-Derived Neurotrophic Factor
Jiang et al. · Frontiers in Psychiatry · 2018
Evidence Level
MODERATEOBJECTIVE
To investigate the epigenetic mechanisms (DNA methylation and histone modifications) through which acupuncture exerts antidepressant effects via the neurotrophic factor BDNF
WHO
Male Sprague-Dawley rats subjected to a chronic stress model of depression
DURATION
28 days of daily treatment
POINTS
Baihui (GV-20, 百會) and Yintang (GV-29, 印堂) - points on the governor vessel meridian
🔬 Study Design
Control
n=10
No intervention
Depression model
n=10
Chronic stress (CUMS)
Fluoxetine
n=10
CUMS + fluoxetine 1.8 mg/kg
Acupuncture
n=10
CUMS + acupuncture at GV-20/GV-29
📊 Results in numbers
Serum BDNF - acupuncture vs. control
Hippocampal BDNF - acupuncture vs. model
HDAC2 - reduction with acupuncture
acH3K9 - improvement with acupuncture
📊 Outcome Comparison
Serum BDNF expression
Anhedonic behavior
This study shows that acupuncture has real antidepressant effects by modifying the expression of genes important for mood, especially BDNF. The research demonstrated that acupuncture works not only at the symptom level but also at the fundamental molecular mechanisms of depression, offering scientific validation for this traditional therapy.
Article summary
Plain-language narrative summary
Depression is one of the most prevalent psychiatric conditions in the world, representing a leading cause of functional disability. Chronic stress is recognized as one of the most important factors in the development, maintenance, and worsening of depression, and can cause profound alterations in brain function, impair the formation of new neurons, and modify synaptic function. Among the mechanisms involved in depression, the significant reduction in the expression of brain-derived neurotrophic factor, known as BDNF, stands out — a protein essential for the development and functioning of the nervous system. This protein is widely distributed in the brain, including areas such as the hippocampus, cerebral cortex, and limbic system structures, and is fundamental to processes of learning, memory, and the formation of neural circuits.
This study investigated the mechanisms by which acupuncture may exert antidepressant effects, focusing specifically on epigenetic modifications of the BDNF gene. The research used a model of depression in rats induced by social isolation and chronic unpredictable mild stress, a well-established methodology that faithfully reproduces the symptoms of human depression. The animals were divided into four groups: control, depression model, treatment with fluoxetine (a standard antidepressant medication), and treatment with acupuncture. Acupuncture treatment was performed at the Baihui (百會) and Yintang (印堂) points, located in the head region, for 28 consecutive days.
The researchers used several advanced laboratory techniques to measure BDNF protein expression in blood and hippocampus, assess histone modifications, and examine DNA methylation patterns in the promoter region of the BDNF gene.
The results showed that chronic stress caused a significant reduction in BDNF protein in both the blood and the hippocampus of the animals, accompanied by typical depression-like behaviors such as reduced pleasure, decreased locomotor activity, and weight loss. Notably, acupuncture was able to reverse these alterations, restoring BDNF levels and improving depressive behaviors in a manner comparable to fluoxetine. The study revealed that stress elevated HDAC2 levels, an enzyme that participates in gene regulation, and reduced acetylation of histone H3K9, a marker associated with gene activation. Acupuncture was able to normalize these epigenetic markers, promoting an environment more favorable to BDNF gene expression.
Interestingly, although no significant differences were found in DNA methylation patterns in the BDNF promoter region, histone modifications proved to be fundamental in explaining the beneficial effects of acupuncture.
For patients suffering from depression, these findings are particularly relevant, as they offer solid scientific evidence that acupuncture can be an effective therapeutic alternative. The study demonstrates that acupuncture not only alleviates depressive symptoms but also acts at the molecular level, correcting fundamental biochemical alterations associated with the disease. For health professionals, these results provide a scientific basis for incorporating acupuncture as a complementary or alternative treatment for depression, especially considering that the effects observed were similar to those of conventional antidepressant medications. The research also suggests that blood BDNF levels may serve as biomarkers to monitor both the severity of depression and the efficacy of acupuncture treatment, offering an objective tool to assess therapeutic response.
The study presents some important limitations that should be considered in interpreting the results. The absence of a specific control group for acupuncture, using nonspecific points or sham acupuncture, limits the ability to determine whether the observed effects are specific to the acupuncture points used. In addition, the investigation focused only on the promoter I region of the BDNF gene, while other regulatory regions may also be involved in the mechanisms of depression. The fact that no significant differences in DNA methylation were found suggests that other regulatory mechanisms, such as microRNAs or post-transcriptional modifications, may be contributing to the observed effects.
Despite these limitations, this work represents an important advance in understanding the molecular mechanisms of acupuncture in the treatment of depression, providing evidence that this ancient therapy acts through specific and measurable biological pathways, which may contribute to its greater acceptance and integration into contemporary medical practice.
Strengths
- 1Detailed investigation of epigenetic mechanisms
- 2Use of multiple analytical techniques (ELISA, Western blot, RT-PCR)
- 3Comparison with a gold-standard medication (fluoxetine)
- 4Comprehensive behavioral assessment
Limitations
- 1Absence of a sham acupuncture control group
- 2Investigation limited only to promoter I of BDNF
- 3Animal model study — requires clinical validation
- 4Small sample size per group
Expert Commentary
Prof. Dr. Hong Jin Pai
PhD in Sciences, University of São Paulo
▸ Clinical Relevance
Depression that is treatment-resistant or only partially responsive to conventional antidepressants represents one of the greatest challenges in chronic pain clinics and consultation-liaison psychiatry. This work by Jiang et al. offers a concrete mechanistic rationale for what many of us have observed clinically: acupuncture at points GV-20 (Baihui, 百會) and GV-29 (Yintang, 印堂) produces antidepressant effects that translate into measurable biochemical alterations, comparable to those induced by fluoxetine. The epigenetic pathway — specifically the modulation of HDAC2 and the acetylation of H3K9 over the hippocampal BDNF promoter — positions acupuncture not as a minor adjuvant, but as an intervention that acts on the same molecular axes targeted by modern pharmacotherapy. For populations that do not tolerate antidepressants or have partial response, these findings support the formal inclusion of acupuncture in multimodal depression management protocols.
▸ Notable Findings
The most relevant finding of the study is not the behavioral improvement itself — that was already expected by those who follow this literature — but rather the normalization of the HDAC2/acH3K9 ratio in the hippocampus of animals treated with acupuncture. HDAC2 is a deacetylase that, when elevated by chronic stress, compresses chromatin and silences the BDNF promoter; acupuncture reversed this silencing in a statistically robust manner (P < 0.01), with no significant difference compared to fluoxetine. Interestingly, DNA methylation at promoter I of BDNF did not significantly change in any of the groups, indicating that the dominant epigenetic mechanism here is post-translational on histones, not CpG methylation. This directs future research toward HDAC inhibitors as potential pharmacological synergists of acupuncture, and reinforces that serum BDNF may function as a biomarker for therapeutic follow-up.
▸ From My Experience
In my practice at the HC-FMUSP Pain Center, we treat a significant number of patients with depression comorbid with chronic pain, and GV-20 is part of virtually every protocol involving a significant emotional component. I have observed that the mood response tends to appear between the third and fifth sessions — earlier than the analgesic response, in fact — and that a cycle of eight to twelve sessions is usually enough to consolidate sustained improvement when combined with an antidepressant at a therapeutic dose. The profile of patients who respond best, in my experience, is those with mild to moderate depression, without psychosis, and with good adherence to regular follow-up. I routinely combine aerobic physical activity with the protocol — known to be neuroprotective via BDNF as well — and this combination produces more durable results than any isolated intervention. The data on HDAC2 in this article resonates with what we see clinically: patients under intense chronic stress take longer to respond, and increasing the frequency of sessions during the first weeks seems to shorten that interval.
Full original article
Read the full scientific study
Frontiers in Psychiatry · 2018
DOI: 10.3389/fpsyt.2018.00102
Access original articleScientific Review

Marcus Yu Bin Pai, MD, PhD
CRM-SP: 158074 | RQE: 65523 · 65524 · 655241
PhD in Health Sciences, University of São Paulo. Board-certified in Pain Medicine, Physical Medicine and Rehabilitation, and Medical Acupuncture. Scientific review and curation of every entry in this library.
Learn more about the author →Medical disclaimer: This content is for educational purposes only and does not replace consultation, diagnosis, or treatment by a qualified professional. Some information may be assisted by artificial intelligence and is subject to inaccuracies. Always consult a physician.
Content reviewed by the medical team at CEIMEC — Integrated Centre for Chinese Medicine Studies, a reference in Medical Acupuncture for over 30 years.
Related articles
Based on this article’s categories